(Reuters) - Carl Zeiss Meditec said in a statement on Friday it had acquired a 5 percent stake in WaveLight, which makes refractive laser and diagnostic systems for refractive eye surgery, used to correct vision and increasingly used in lieu of glasses.
"At this point in time the acquisition of stock demonstrates that we have an interest in WaveLight in principle," Carl Zeiss Meditec investor relations director Jens Brajer said.
Read more at Reuters.com Mergers News
"At this point in time the acquisition of stock demonstrates that we have an interest in WaveLight in principle," Carl Zeiss Meditec investor relations director Jens Brajer said.
Read more at Reuters.com Mergers News
No comments:
Post a Comment